Periostin and tumor-stroma interactions in non-small cell lung cancer
Authors:
Open Access
- 14 September 2016
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (5) , 3804-3810
Abstract
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer‑associated mortality globally. Interactions of the cancer cells with the tumor microenvironment are essential carcinogenic features for the majority of solid tumors, such as pancreatic cancer. The present study investigated the role of stromal activation in NSCLC and analyzed the surgical specimens of 93 patients by immunohistochemistry with regard to periostin (an extracellular matrix protein), α‑smooth muscle actin (α‑SMA; a marker of myofibroblasts) and cluster of differentiation 31 (CD31; a marker of endothelial cells), and the activated stroma index. There was a trend towards reduced overall survival for patients with high periostin expression (hazard ratio, 1.80; 95% confidence interval, 0.99‑3.27; P=0.050). No significant correlations with overall survival were identified for α‑SMA (P=0.930), CD31 (P=0.923), collagen (P=0.441) or the activated stroma index (P=0.706). In a multivariable analysis, the histological tumor subtype, tumor stage, lymph node involvement and resection status were independent prognostic factors in NSCLC, but none of the investigated immunohistochemical markers were prognostic factors. Thus, the tumor microenvironment and stroma activation did not prove to be of prognostic relevance for lung cancer, as it has been previously described for pancreatic cancer. Other markers of the microenvironment of NSCLC may be of higher prognostic value, pointing towards tumor‑type specific effects.Keywords
This publication has 30 references indexed in Scilit:
- Overexpression of periostin predicts poor prognosis in non-small cell lung cancerOncology Letters, 2013
- Periostin expression and epithelial-mesenchymal transition in cancer: a review and an updateVirchows Archiv, 2011
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Angiogenesis in pre-malignant conditionsEuropean Journal of Cancer, 2009
- Cancer-related inflammationNature, 2008
- Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cellsInternational Journal of Cancer, 2008
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Suppression of Anchorage-Independent Growth of Human Cancer Cell Lines by the TRIF52/Periostin/OSF-2 GeneExperimental Cell Research, 2002
- Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor PrognosisAnnals of Surgical Oncology, 2001
- Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancerInternational Journal of Cancer, 1997